Scher HI - Search Results

1

Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.

Breen KE, Symecko H, Spielman K, Gebert R, Shah IH, Pundock S, Batson M, Narayan VK, Stadler ZK, Autio KA, Abida W, Danila DC, Scher HI, Morris MJ, Hamilton JG, Robson ME, Domchek SM, Carlo MI. Breen KE, et al. Among authors: scher hi. J Urol. 2023 May;209(5):918-927. doi: 10.1097/JU.0000000000003186. Epub 2023 Mar 28. J Urol. 2023. PMID: 36974724 Free PMC article.

2

Clinical states in prostate cancer: toward a dynamic model of disease progression.

Scher HI, Heller G. Scher HI, et al. Urology. 2000 Mar;55(3):323-7. doi: 10.1016/s0090-4295(99)00471-9. Urology. 2000. PMID: 10699601 Free article. No abstract available.

3

Novel strategies and therapeutics for the treatment of prostate carcinoma.

Morris MJ, Scher HI. Morris MJ, et al. Among authors: scher hi. Cancer. 2000 Sep 15;89(6):1329-48. doi: 10.1002/1097-0142(20000915)89:6<1329::aid-cncr19>3.0.co;2-q. Cancer. 2000. PMID: 11002230 Review.

4

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.

Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross JS, Cordon-Cardo C. Osman I, et al. Among authors: scher hi. Clin Cancer Res. 2001 Sep;7(9):2643-7. Clin Cancer Res. 2001. PMID: 11555574

5

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer.

Morris MJ, Tong WP, Cordon-Cardo C, Drobnjak M, Kelly WK, Slovin SF, Terry KL, Siedlecki K, Swanson P, Rafi M, DiPaola RS, Rosen N, Scher HI. Morris MJ, et al. Among authors: scher hi. Clin Cancer Res. 2002 Mar;8(3):679-83. Clin Cancer Res. 2002. PMID: 11895895 Clinical Trial.

6

HER-2 profiling and targeting in prostate carcinoma.

Morris MJ, Reuter VE, Kelly WK, Slovin SF, Kenneson K, Verbel D, Osman I, Scher HI. Morris MJ, et al. Among authors: scher hi. Cancer. 2002 Feb 15;94(4):980-6. Cancer. 2002. PMID: 11920466 Free article. Clinical Trial.

7

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.

Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, Verbel D, Schwartz L, Larson SM, Scher HI. Morris MJ, et al. Among authors: scher hi. Urology. 2002 Jun;59(6):913-8. doi: 10.1016/s0090-4295(02)01509-1. Urology. 2002. PMID: 12031380

8

Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies.

Morris MJ, Scher HI. Morris MJ, et al. Among authors: scher hi. Surg Oncol. 2002 Jun;11(1-2):13-23. doi: 10.1016/s0960-7404(02)00006-3. Surg Oncol. 2002. PMID: 12031864 Review.

9

Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine.

Morris MJ, Santamauro J, Shia J, Schwartz L, Vander Els N, Kelly K, Scher H. Morris MJ, et al. Urology. 2002 Dec;60(6):1111. doi: 10.1016/s0090-4295(02)01921-0. Urology. 2002. PMID: 12475686 Review.

10

Clinical approaches to osseous metastases in prostate cancer.

Morris MJ, Scher HI. Morris MJ, et al. Among authors: scher hi. Oncologist. 2003;8(2):161-73. doi: 10.1634/theoncologist.8-2-161. Oncologist. 2003. PMID: 12697941 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters